Epigenetic Inactivation of KLF4 is Associated with Urothelial Cancer Progression and Early Recurrence
Abstract
Purpose:
KLF4 is a transcription factor with divergent functions in different malignancies. We analyzed KLF4 expression and DNA methylation, and their clinical relevance and biological function in urothelial cancer.
Materials and Methods:
Immunohistochemistry and Sequenom™ MassARRAY® were done to detect the expression and promoter methylation of KLF4 in urothelial cancer tissues. The association of the recurrence-free survival rate and decreased KLF4 or KLF4 methylation status was analyzed by the Kaplan-Meier method, Cox regression analysis and ROC assay. Lentivirus based KLF4 over expression and dsRNA mediated knockdown were used to detect KLF4 functions in urothelial cancer in vitro and in vivo.
Results:
KLF4 was down-regulated in urothelial cancer due to promoter hypermethylation. Each correlated with recurrence-free survival in patients with nonmuscle invasive bladder cancer after transurethral resection of bladder cancer, which potentiates them as valuable predictive biomarkers for early recurrence. Moreover, in and ex vivo experiments showed that KLF4 suppressed urothelial cancer cell growth, migration and invasion inhibited the epithelial-to-mesenchymal transition.
Conclusions:
KLF4 may function as a tumor suppressor gene in urothelial cancer since down-regulation of KLF4 by promoter hypermethylation would promote cancer progression. In addition, decreased expression of KLF4 or its promoter hypermethylation may have predictive value for early recurrence in patients with nonmuscle invasive bladder cancer.
References
- 1 : Cancer statistics, 2012. CA Cancer J Clin2012; 62: 10. Google Scholar
- 2 : Natural history and treatment of low and high risk superficial bladder tumors. J Urol1988; 139: 283. Abstract, Google Scholar
- 3 : Molecular genetics of Kruppel, a gene required for segmentation of the Drosophila embryo. Nature1985; 313: 27. Google Scholar
- 4 : Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem1996; 271: 20009. Google Scholar
- 5 : A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem1996; 271: 31384. Google Scholar
- 6 : Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res2005; 65: 2746. Google Scholar
- 7 : Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene2004; 23: 395. Google Scholar
- 8 : Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res2008; 68: 4631. Google Scholar
- 9 : KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther2005; 4: 1216. Google Scholar
- 10 : Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma. Clin Cancer Res2009; 15: 5688. Google Scholar
- 11 : Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res2010; 70: 10182. Google Scholar
- 12 : Loss of Kruppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression. Clin Cancer Res2006; 12: 6395. Google Scholar
- 13 : Dysregulated KLF4 and vitamin D receptor signaling promotes hepatocellular carcinoma progression. Gastroenterology2012; 143: 799. Google Scholar
- 14 : Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res2000; 60: 6488. Google Scholar
- 15 : Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene2005; 24: 1491. Google Scholar
- 16 : KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol Ther2005; 4: 1401. Google Scholar
- 17 : Identification of PMF1 methylation in association with bladder cancer progression. Clin Cancer Res2008; 14: 8236. Google Scholar
- 18 : Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A1996; 93: 9821. Google Scholar
- 19 : Relation between hypomethylation of long interspersed nucleotide elements and risk of neural tube defects. Am J Clin Nutr2010; 91: 1359. Google Scholar
- 20 : Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Neoplasia2010; 12: 20. Google Scholar
- 21 : Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun2003; 308: 251. Google Scholar
- 22 : Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res2004; 64: 6002. Google Scholar
- 23 : Epithelial-mesenchymal transitions in development and disease. Cell2009; 139: 871. Google Scholar
- 24 : An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J2010; 277: 1684. Google Scholar
- 25 : Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia2011; 13: 601. Google Scholar
- 26 : Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor beta-initiated prostate cancer epithelial-mesenchymal transition. Mol Cell Biol2012; 32: 941. Google Scholar
